An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19()

BACKGROUND AND AIMS: Molnupiravir is a newer oral antiviral drug that has recently received emergency use authorization (EUA) in USA, UK and India. We aim to conduct an update on our previous systematic review to provide practical clinical guideline for using molnupiravir in patients with COVID-19....

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Awadhesh Kumar, Singh, Akriti, Singh, Ritu, Misra, Anoop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755553/
https://www.ncbi.nlm.nih.gov/pubmed/35051686
http://dx.doi.org/10.1016/j.dsx.2022.102396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755553/
https://www.ncbi.nlm.nih.gov/pubmed/35051686
http://dx.doi.org/10.1016/j.dsx.2022.102396

Ejemplares similares